1. Pink Sheet
  2. >>Geography
  3. >>Asia
  4. >>Japan

PhRMA Promotes Cluster Concept In Japan Reform Wish List

Holistic Changes Needed, US Group Says

 
• By Ian Haydock

US industry association promotes an exchanges with Japan on bioclusters, while continuing to push for holistic debate on reforms to the country’s national healthcare system and changes to reimbursement pricing it sees as supporting innovation.

wish list of policy change for pharma has become longer recently
US innovator group lists Japan reform items • Source: Shutterstock

The US research-based industry group The Pharmaceutical and Research Manufacturers of America (PhRMA) is continuing to advocate for broad debate around reforms to Japan’s healthcare and drug reimbursement pricing systems, as it seeks to create an environment it sees as conducive to sustainable innovation, patient access to new drugs and economic benefits.

While many of the themes are familiar, one particular emphasis this year was a healthcare innovation roundtable, under which the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

Industry Excellence Celebrated At Citeline Japan Awards

 
• By Ian Haydock

Excellence, innovation and deal-making across the Japanese biopharma sector were celebrated at the Citeline Japan Awards 2025, held in Tokyo on 21 October.

US Confirms 15% Tariff On Japanese Drugs, But Confusion Lingers

 
• By Lisa Takagi

After tough negotiations which won the country a lower US levy on pharmaceuticals, there still appears to be some confusion within the Japanese government following President Trump's latest announcement on global pharma tariffs.

Publisher’s Spotlight: Shortlist Unveiled For Citeline Japan Awards

 
• By Ian Haydock

Shortlists of potential winners in all categories of the Citeline Japan Awards 2025 have now been released. Join us at the event in Tokyo on October 21, it’s not too late to book your table!

Japan Expands Essential Drug List For Economic Security

 
• By Lisa Takagi

Japan's government has already allocated more than $400m to repatriate manufacturing of important drugs and continues to provide support as it expands a list of "national security" drugs.

More from Asia

ACCESS Consortium To Harmonize Clinical Trial Process Across Five Nations

 
• By Eliza Slawther

Clinical trial sponsors could soon benefit from a streamlined clinical trial approval process in Australia, Canada, Singapore, Switzerland and the UK under a new ACCESS Consortium project.

China NMPA Accelerates Market Access For Imported Medicines

 
• By Xu Hu

China's NMPA announces new measures designed to speed up access to imported medicines already launched abroad ahead of their final formal regulatory approval in China.

Pharma Encouraged To Test Singapore’s eCTD System Before April 2026 Launch

 
• By Neena Brizmohun

The Health Sciences Authority wants drug companies to familiarize themselves with its electronic common technical document platform before it goes live next year.